Akebia Therapeutics, Inc. Common Stock (NASDAQ: AKBA) last traded at $0.907, down 1.39% on the session. The quote above updates while this page is open; the figures below are drawn from Akebia Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Akebia Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker AKBA. Its market capitalisation is $251.22 million.
Valuation measures for Akebia Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $251.22M |
|---|---|
| Enterprise value | $420.32M |
| Price / sales | 1.15 |
| Price / book | 10.04 |
| Beta | 1.14 |
Trailing-twelve-month figures tagged in Akebia Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $219.06M |
|---|---|
| Net income (TTM) | -$29.67M |
| EPS (TTM) | -$0.110 |
| Operating margin | -6.90% |
| Return on equity | -118.58% |
| Cash | $155.55M |
Range and volume for AKBA over the past 52 weeks.
| 52-week high | $3.32 |
|---|---|
| 52-week low | $0.814 |
| Volume | 6.45M |
| Average volume | 4.96M |
| Previous close | $0.919 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.